Advisory Services Network’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.39M Buy
88,887
+2,911
+3% +$170K 0.07% 289
2025
Q4
$4.64M Sell
85,976
-19,348
-18% -$931K 0.07% 318
2025
Q3
$4.75M Sell
105,324
-2,896
-3% -$135K 0.07% 307
2025
Q2
$4.69M Sell
108,220
-12,440
-10% -$611K 0.08% 289
2025
Q1
$7.36M Buy
120,660
+19,410
+19% +$1.13M 0.14% 159
2024
Q4
$5.73M Buy
101,250
+13,634
+16% +$762K 0.11% 212
2024
Q3
$3.64M Hold
87,616
0.08% 290
2024
Q2
$3.64M Sell
87,616
-31,807
-27% -$1.42M 0.08% 290
2024
Q1
$6.48M Buy
119,423
+38,163
+47% +$1.94M 0.14% 163
2023
Q4
$4.17M Sell
81,260
-26,910
-25% -$1.41M 0.1% 223
2023
Q3
$6.28M Sell
108,170
-24,162
-18% -$1.48M 0.17% 129
2023
Q2
$8.46M Buy
132,332
+13,183
+11% +$884K 0.23% 92
2023
Q1
$8.26M Buy
119,149
+6,012
+5% +$424K 0.23% 86
2022
Q4
$8.14M Buy
113,137
+2,328
+2% +$176K 0.25% 83
2022
Q3
$7.88M Sell
110,809
-20,688
-16% -$1.5M 0.28% 77
2022
Q2
$10.1M Buy
131,497
+41,156
+46% +$3.13M 0.35% 53
2022
Q1
$6.6M Buy
90,341
+3,868
+4% +$260K 0.19% 114
2021
Q4
$5.39M Sell
86,473
-11,841
-12% -$695K 0.16% 160
2021
Q3
$5.82M Buy
98,314
+15,264
+18% +$1.01M 0.19% 128
2021
Q2
$5.55M Buy
83,050
+2,714
+3% +$177K 0.18% 138
2021
Q1
$5.07M Sell
80,336
-2,519
-3% -$157K 0.19% 129
2020
Q4
$5.14M Sell
82,855
-5,574
-6% -$343K 0.21% 115
2020
Q3
$5.33M Sell
88,429
-11,203
-11% -$674K 0.25% 93
2020
Q2
$5.86M Buy
99,632
+52,581
+112% +$3.15M 0.32% 69
2020
Q1
$2.62M Sell
47,051
-17,796
-27% -$1.09M 0.17% 148
2019
Q4
$4.16M Buy
64,847
+31,449
+94% +$1.8M 0.22% 116
2019
Q3
$1.51M Hold
33,398
0.09% 289
2019
Q2
$1.51M Buy
33,398
+4,504
+16% +$210K 0.09% 289
2019
Q1
$1.38M Sell
28,894
-21,534
-43% -$1.07M 0.1% 278
2018
Q4
$2.62M Buy
50,428
+12,169
+32% +$654K 0.23% 112
2018
Q3
$2.38M Sell
38,259
-1,887
-5% -$112K 0.17% 146
2018
Q2
$2.33M Buy
40,146
+3,236
+9% +$175K 0.18% 147
2018
Q1
$2.33M Buy
36,910
+428
+1% +$27.5K 0.19% 125
2017
Q4
$2.24M Buy
36,482
+5,224
+17% +$327K 0.19% 123
2017
Q3
$1.99M Buy
31,258
+8,911
+40% +$520K 0.23% 111
2017
Q2
$1.25M Sell
22,347
-1,194
-5% -$65K 0.16% 166
2017
Q1
$1.28M Buy
+23,541
New +$1.29M 0.19% 131
2016
Q3
$1.12M Buy
20,845
+4,317
+26% +$277K 0.21% 112
2016
Q2
$1.22M Sell
16,528
-300
-2% -$21.2K 0.28% 79
2016
Q1
$1.07M Buy
16,828
+11,540
+218% +$728K 0.29% 76
2015
Q4
$364K Buy
5,288
+616
+13% +$40.7K 0.12% 218
2015
Q3
$277K Buy
4,672
+1,171
+33% +$74.3K 0.08% 239
2015
Q2
$236K Buy
3,501
+2
+0.1% +$132 0.07% 262
2015
Q1
$220K Buy
3,499
+88
+3% +$5.51K 0.06% 276
2014
Q4
$213K Buy
+3,411
New +$192K 0.07% 237
2014
Q1
Sell
-1,486
Closed -$79K 271
2013
Q4
$79K Buy
+1,486
New +$75.7K 0.04% 268

Other funds holding BMY

Advisory Services Network's BMY Position: Q1 2026 in Review

Advisory Services Network increased its Bristol-Myers Squibb (BMY) stake by 3.4% in Q1 2026, buying an estimated $170K and bringing the position to 88,887 shares worth $5.39M. The position accounts for 0.07% of the portfolio, ranked #289.

Advisory Services Network first reported a position in BMY in Q4 2013 and has held it in 46 quarters since. The position peaked at $10.1M in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Advisory Services Network held 88,887 shares of Bristol-Myers Squibb worth $5.39M as of Q1 2026.
  • Advisory Services Network bought 2,911 Bristol-Myers Squibb shares in Q1 2026, an estimated $170K.
  • Bristol-Myers Squibb made up 0.07% of Advisory Services Network's portfolio in Q1 2026, its #289 holding.
  • Advisory Services Network first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 46 quarters since.
  • Advisory Services Network's Bristol-Myers Squibb position peaked at $10.1M in Q2 2022.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.